Andrew Steer
Overview
Explore the profile of Andrew Steer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
14002
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tuckerman J, Anderson J, Alafaci A, Licciardi P, Steer A, Barr I, et al.
Arch Dis Child
. 2025 Mar;
PMID: 40089271
No abstract available.
2.
Thomas H, Mullane M, Enkel S, McRae T, Amgarth-Duff I, Carapetis J, et al.
EClinicalMedicine
. 2024 Dec;
77:102793.
PMID: 39649132
Background: Healthy skin is important for maintaining overall physical and cultural health and wellbeing. However, remote-living Australian Aboriginal children contend with disproportionally high rates of (Strep A) infected impetigo. The...
3.
Jones B, Marangou J, Yan J, Ralph A, Mitchell A, Kaethner A, et al.
BMJ Open
. 2024 Oct;
14(10):e083467.
PMID: 39424380
Introduction: Rheumatic heart disease (RHD) is underdiagnosed globally resulting in missed treatment opportunities and adverse clinical outcomes. We describe the protocol for a study which aims to co-design, implement and...
4.
Thomas H, Enkel S, Mullane M, McRae T, Barnett T, Carapetis J, et al.
Lancet Child Adolesc Health
. 2024 Oct;
8(11):809-820.
PMID: 39393383
Background: Skin infections affect physical health and, through stigma, social-emotional health. When untreated, they can cause life-threatening conditions. We aimed to assess the effect of a holistic, co-designed, region-wide skin...
5.
Mitchell E, Tavui A, Andersson S, Lake S, Koroivueti A, Koroivueta J, et al.
Lancet Reg Health West Pac
. 2024 Sep;
51:101194.
PMID: 39295851
Background: Fiji has among the highest global reported prevalence of scabies. Mass drug administration (MDA) has been identified as a potentially effective strategy to control scabies, but acceptability of MDA...
6.
Enkel S, Wong B, Hla T, Pickering J, Barnett T, Thomas H, et al.
mSphere
. 2024 Sep;
9(10):e0051324.
PMID: 39254050
Controlled human infection (CHI) models can provide insights into transmission of pathogens such as (Strep A). As part of the Controlled Human Infection with Penicillin for (CHIPS) trial, we explored...
7.
Gwee A, Steer A, Phongluxa K, Luangphaxay C, Senggnam K, Philavanh A, et al.
Lancet Reg Health West Pac
. 2024 Aug;
49:101144.
PMID: 39109221
Background: Ivermectin, an effective treatment for scabies, is not licensed for children weighing <15 kg. Pharmacokinetic modelling has shown a 3 mg dose in young children (2-4 years, weighing 10-14 ...
8.
Jacobson J, Fabri L, Osowicki J, Shanthikumar S, Costa A, Ortika B, et al.
PLoS One
. 2024 Jun;
19(6):e0304861.
PMID: 38917227
Pleural empyema is a serious complication of pneumonia in children. Negative bacterial cultures commonly impede optimal antibiotic therapy. To improve bacterial identification, we developed a molecular assay and evaluated its...
9.
Rwebembera J, Ndagire E, Carvalho N, Webel A, Sable C, Okello E, et al.
Am Heart J
. 2024 May;
275:74-85.
PMID: 38797460
Background: Rheumatic Heart Disease (RHD) persists as a major cardiovascular driver of mortality and morbidity among young people in low-and middle-income countries. Secondary antibiotic prophylaxis (SAP) with penicillin remains the...
10.
Carville K, Meagher N, Abo Y, Manski-Nankervis J, Fielding J, Steer A, et al.
BMC Prim Care
. 2024 Apr;
25(1):117.
PMID: 38632513
Background: Reducing antibiotic use in Australia, and the subsequent impact on antimicrobial resistance, requires multiple, sustained approaches with appropriate resources and support. Additional strategies to reduce antibiotic prescribing include effective...